In this article, we will discuss Olaparib (Drug Interaction-2). So, let’s get started.
Strong and Moderate CYP3A Inhibitors
Coadministration of CYP3A inhibitors can increase olaparib concentrations, which may increase the risk for adverse reactions. Avoid coadministration of strong or moderate CYP3A inhibitors. If the strong or moderate inhibitor must be coadministered, reduce the dose of Olaparib.